Evaluating the Impact of Assessing During Peer Review the CONSORT Checklist Submitted by Authors
1 other identifier
interventional
24
1 country
1
Brief Summary
Randomised trials are considered the gold standard in medical research. The CONSORT (Consolidated Standards of Reporting Trials) Statement aims to improve the quality of reporting of randomised trials. Without transparent reporting, readers cannot judge the reliability and validity of trial findings, and therefore these findings cannot inform clinical practice. Different stakeholders, including biomedical journals, have taken different actions to try to improve author adherence to CONSORT. The most popular action among biomedical journals is to instruct authors to submit a completed RG checklist with page numbers indicating where the CONSORT items are addressed when they submit their manuscript. However, this measure alone has been proven not to be effective. In this study, the investigators intend to evaluate in a real editorial context whether assessing during peer review the consistency between the submitted CONSORT checklist and the information reported in the manuscripts of randomised trials, as well as to provide feedback to authors on the inconsistencies found, improves the completeness of reporting of published trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2018
CompletedFirst Posted
Study publicly available on registry
November 23, 2018
CompletedStudy Start
First participant enrolled
December 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2019
CompletedMay 21, 2019
May 1, 2019
4 months
November 21, 2018
May 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall completeness of reporting
Proportion of adequately reported CONSORT items in the first revised manuscript
Following manuscript revision (usually 2-3 months)
Secondary Outcomes (2)
Completeness of reporting for each item
Following manuscript revision (usually 2-3 months)
Time to perform the evaluation
Following the evaluation of reporting inconsistencies (1 week)
Study Arms (2)
Intervention arm
EXPERIMENTALEvaluation of reporting inconsistencies between the CONSORT checklist and the information reported in the manuscript. Feedback is provided to authors.
Control arm
OTHERStandard peer review process.
Interventions
1. The completed CONSORT checklist submitted by authors of manuscripts randomised to the intervention group will be assessed by the lead investigator (DB) as to whether it is consistent with the information that was actually reported in the manuscript. This evaluation will be focused on 8 core CONSORT items. 2. DB will produce a standardised report containing precise requests for authors in order to improve the completeness of reporting of the items where reporting inconsistencies were found. This report will consist of a brief introduction followed by a point by point description of the inconsistencies found together with precise requests related to the information missing and examples extracted from CONSORT. DB will upload this report to the submission on the managing system of the journal (Scholar One) to make it accessible to the handling editor of the manuscript. 3. This editor will include the report in the letter to authors alongside the standard peer review reports.
Eligibility Criteria
You may qualify if:
- Manuscripts will be eligible if:
- They have been submitted to BMJ Open,
- They are original research submissions reporting the results of a randomised trial, and
- They have passed the first editorial filters and have been subsequently sent out for peer review.
- Authors of these manuscripts have provided a completed CONSORT checklist.
- According to the official CONSORT extensions, the investigators will also consider other study designs (cluster, non-inferiority and equivalence, pragmatic, N-of-1 trials, Pilot and feasibility, and within person trials), and different intervention types (Herbal, non-pharmacologic, acupuncture and Chinese herbal medicine formulas) in all areas of clinical specialty.
You may not qualify if:
- Protocols of randomised trials
- Secondary trial analysis studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitat Politècnica de Catalunyalead
- University of Liverpoolcollaborator
- The BMJcollaborator
Study Sites (1)
BMJ Open
London, WC1H 9JR, United Kingdom
Related Publications (1)
Blanco D, Schroter S, Aldcroft A, Moher D, Boutron I, Kirkham JJ, Cobo E. Effect of an editorial intervention to improve the completeness of reporting of randomised trials: a randomised controlled trial. BMJ Open. 2020 May 18;10(5):e036799. doi: 10.1136/bmjopen-2020-036799.
PMID: 32430454DERIVED
Study Officials
- STUDY CHAIR
Sara Schroter
The BMJ, London
- STUDY CHAIR
Adrian Aldcroft
The BMJ, London
- STUDY CHAIR
David Moher
Ottawa Hospital Research Institute, Ottawa
- STUDY CHAIR
Isabelle Boutron
Paris Descartes University, Paris
- STUDY CHAIR
Jamie J Kirkham
University of Liverpool, Liverpool
- STUDY CHAIR
Erik Cobo
Universitat Politècnica de Catalunya, Barcelona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 21, 2018
First Posted
November 23, 2018
Study Start
December 7, 2018
Primary Completion
April 13, 2019
Study Completion
April 13, 2019
Last Updated
May 21, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share
The content of the interventional peer review reports will appear as part of the review history of the manuscripts. However, in order to protect confidentiality, no dataset including individual manuscript data or outcome data identifying the performance of individual participants will be released. When the study is finished, DB will assign a study number to each paper and store that code with the manuscript ID, password protect it, and store it (File 1) in the BMJ Google Drive folder for the study. In this file, we will also include all identifying variables (Submission date, Trial registration number, Title, Latest editorial decision, applicable CONSORT extensions). For the file containing the peer review reports and the study outcomes (File 2), DB will strip all identifying variables other than the study code and store that file separate from File 1. DB will stick all study files in one folder, compress this folder using WinZip, password protect it, and store it in the same folder.